Variant report
Variant | nsv528911 |
---|---|
Chromosome Location | chr11:55083434-55156434 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:145)
- CpG islands (count:610)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:55131951-55132124 | A549 | lung: | n/a | chr11:55131997-55132008 chr11:55131973-55131984 |
2 | CEBPB | chr11:55143436-55143619 | A549 | lung: | n/a | n/a |
3 | CEBPB | chr11:55113744-55114010 | IMR90 | lung: | n/a | chr11:55113873-55113884 |
4 | CEBPB | chr11:55113743-55114014 | HepG2 | liver: | n/a | chr11:55113873-55113884 |
5 | CEBPB | chr11:55131841-55132160 | HepG2 | liver: | n/a | chr11:55131997-55132008 chr11:55131973-55131984 |
6 | CTCF | chr11:55125107-55125446 | K562 | blood: | n/a | n/a |
7 | CTCF | chr11:55102008-55102079 | GM20000 | blood: | n/a | n/a |
8 | CTCF | chr11:55125145-55125392 | LNCaP | prostate: | n/a | n/a |
9 | CTCF | chr11:55125220-55125370 | Caco-2 | colon: | n/a | n/a |
10 | CTCF | chr11:55125166-55125347 | K562 | blood: | n/a | n/a |
11 | CTCF | chr11:55125180-55125330 | NB4 | blood: | n/a | n/a |
12 | CTCF | chr11:55125175-55125313 | GM20000 | blood: | n/a | n/a |
13 | CTCF | chr11:55125132-55125369 | HCT-116 | colon: | n/a | n/a |
14 | CTCF | chr11:55125165-55125305 | HepG2 | liver: | n/a | n/a |
15 | CTCF | chr11:55125180-55125330 | A549 | lung: | n/a | n/a |
16 | CTCF | chr11:55125100-55125250 | Hela-S3 | cervix: | n/a | n/a |
17 | CTCF | chr11:55125152-55125355 | HepG2 | liver: | n/a | n/a |
18 | CTCF | chr11:55125186-55125313 | GM12878 | blood: | n/a | n/a |
19 | CTCF | chr11:55125040-55125059 | GM13976 | blood: | n/a | n/a |
20 | CTCF | chr11:55125100-55125250 | MCF-7 | breast: | n/a | n/a |
21 | CTCF | chr11:55125204-55125226 | GM19238 | blood: | n/a | n/a |
22 | CTCF | chr11:55125117-55125451 | K562 | blood: | n/a | n/a |
23 | CTCF | chr11:55125168-55125315 | A549 | lung: | n/a | n/a |
24 | CTCF | chr11:55125100-55125250 | GM12873 | blood: | n/a | n/a |
25 | CTCF | chr11:55125260-55125410 | HCT-116 | colon: | n/a | n/a |
26 | CTCF | chr11:55125101-55125454 | T-47D | breast: | n/a | n/a |
27 | CTCF | chr11:55125180-55125330 | BE2_C | brain: | n/a | n/a |
28 | CTCF | chr11:55125220-55125370 | A549 | lung: | n/a | n/a |
29 | CTCF | chr11:55125140-55125290 | GM12871 | blood: | n/a | n/a |
30 | CTCF | chr11:55125040-55125190 | HCT-116 | colon: | n/a | n/a |
31 | CTCF | chr11:55125130-55125442 | H1-hESC | embryonic stem cell: | n/a | n/a |
32 | CTCF | chr11:55125140-55125290 | GM12874 | blood: | n/a | n/a |
33 | CTCF | chr11:55125200-55125350 | GM06990 | blood: | n/a | n/a |
34 | CTCF | chr11:55125120-55125270 | GM12874 | blood: | n/a | n/a |
35 | CTCF | chr11:55125100-55125250 | GM12871 | blood: | n/a | n/a |
36 | CTCF | chr11:55125140-55125290 | NHEK | skin: | n/a | n/a |
37 | CTCF | chr11:55125100-55125250 | GM12878 | blood: | n/a | n/a |
38 | CTCF | chr11:55125120-55125270 | GM12867 | blood: | n/a | n/a |
39 | CTCF | chr11:55125169-55125257 | A549 | lung: | n/a | n/a |
40 | CTCF | chr11:55125121-55125385 | SK-N-SH_RA | brain: | n/a | n/a |
41 | CTCF | chr11:55125183-55125254 | Fibrobl | skin: | n/a | n/a |
42 | CTCF | chr11:55125068-55125430 | A549 | lung: | n/a | n/a |
43 | CTCF | chr11:55125140-55125290 | GM12873 | blood: | n/a | n/a |
44 | CTCF | chr11:55125100-55125250 | HBMEC | blood vessel: | n/a | n/a |
45 | CTCF | chr11:55125257-55125280 | GM13977 | blood: | n/a | n/a |
46 | CTCF | chr11:55125151-55125361 | MCF-7 | breast: | n/a | n/a |
47 | CTCF | chr11:55125160-55125310 | GM12864 | blood: | n/a | n/a |
48 | CTCF | chr11:55137360-55137510 | NHDF-neo | bronchial: | n/a | n/a |
49 | CTCF | chr11:55125120-55125270 | GM12865 | blood: | n/a | n/a |
50 | CTCF | chr11:55125200-55125350 | GM12873 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:55135222-55135272 | ECC-1 | luminal epithelium: | n/a |
2 | chr11:55109885-55109935 | HAEpiC | amniotic membrane: | n/a |
3 | chr11:55110233-55110283 | HMEC | breast: | n/a |
4 | chr11:55109885-55109935 | PFSK-1 | brain: | n/a |
5 | chr11:55110562-55110612 | HCPEpiC | choroid plexus: | n/a |
6 | chr11:55109885-55109935 | MCF-7 | breast: | n/a |
7 | chr11:55135046-55135096 | AoSMC | blood vessel: | n/a |
8 | chr11:55135656-55135706 | SK-N-SH_RA | brain: | n/a |
9 | chr11:55134268-55134318 | HPAEpiC | pulmonary alveolar: | n/a |
10 | chr11:55135656-55135706 | HRPEpiC | eye: | n/a |
11 | chr11:55135337-55135387 | T-47D | breast: | n/a |
12 | chr11:55135222-55135272 | AG09309 | skin: | n/a |
13 | chr11:55135046-55135096 | ProgFib | skin: | n/a |
14 | chr11:55135656-55135706 | RPTEC | kidney: | n/a |
15 | chr11:55110562-55110612 | HPAEpiC | pulmonary alveolar: | n/a |
16 | chr11:55135337-55135387 | HRCEpiC | kidney: | n/a |
17 | chr11:55135337-55135387 | HEK293 | kidney: | embryo |
18 | chr11:55134268-55134318 | HEK293 | kidney: | embryo |
19 | chr11:55134268-55134318 | HepG2 | liver: | n/a |
20 | chr11:55135656-55135706 | BJ | skin: | n/a |
21 | chr11:55135337-55135387 | U87 | brain: | n/a |
22 | chr11:55111658-55111708 | HRE | kidney: | n/a |
23 | chr11:55135046-55135096 | HCT-116 | colon: | n/a |
24 | chr11:55110562-55110612 | SAEC | small airway: | n/a |
25 | chr11:55110233-55110283 | GM12891 | blood: | n/a |
26 | chr11:55135656-55135706 | AG04449 | skin: | fetal |
27 | chr11:55135656-55135706 | HRCEpiC | kidney: | n/a |
28 | chr11:55110562-55110612 | BJ | skin: | n/a |
29 | chr11:55111658-55111708 | GM06990 | blood: | n/a |
30 | chr11:55110562-55110612 | ovcar-3 | ovarian: | n/a |
31 | chr11:55135331-55135381 | HCPEpiC | choroid plexus: | n/a |
32 | chr11:55135656-55135706 | AG10803 | skin: | n/a |
33 | chr11:55111658-55111708 | T-47D | breast: | n/a |
34 | chr11:55110562-55110612 | MCF10A-Er-Src | breast: | n/a |
35 | chr11:55135331-55135381 | SK-N-SH | brain: | n/a |
36 | chr11:55135222-55135272 | GM19239 | blood: | n/a |
37 | chr11:55110233-55110283 | HEK293 | kidney: | embryo |
38 | chr11:55135046-55135096 | GM12892 | blood: | n/a |
39 | chr11:55110562-55110612 | AG04450 | lung: | fetal |
40 | chr11:55135046-55135096 | HRE | kidney: | n/a |
41 | chr11:55109885-55109935 | BJ | skin: | n/a |
42 | chr11:55135331-55135381 | SKMC | muscle: | n/a |
43 | chr11:55135222-55135272 | HUVEC | blood vessel: | n/a |
44 | chr11:55135331-55135381 | AG10803 | skin: | n/a |
45 | chr11:55135656-55135706 | HCM | heart: | n/a |
46 | chr11:55109885-55109935 | HPAEpiC | pulmonary alveolar: | n/a |
47 | chr11:55110233-55110283 | ECC-1 | luminal epithelium: | n/a |
48 | chr11:55135046-55135096 | IMR90 | lung: | fetal |
49 | chr11:55135331-55135381 | NT2-D1 | testis: | n/a |
50 | chr11:55134268-55134318 | SK-N-SH | brain: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR4A11P | TF binding region |
OR4A9P | TF binding region |
OR4A16 | TF binding region |
OR4A12P | TF binding region |
OR4A15 | TF binding region |
OR4A11P | CpG island |
OR4A9P | CpG island |
OR4A16 | CpG island |
OR4A12P | CpG island |
OR4A15 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1216155 | chr11:55083434-55083435 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs114073578 | chr11:55083441-55083442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561578962 | chr11:55083452-55083453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs61489186 | chr11:55083458-55083459 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs182125255 | chr11:55083495-55083496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs370232147 | chr11:55083504-55083505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1216156 | chr11:55083524-55083525 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs533372387 | chr11:55083526-55083527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1364766 | chr11:55083536-55083537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186147842 | chr11:55083537-55083538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191874087 | chr11:55083545-55083546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183974384 | chr11:55083568-55083569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568429940 | chr11:55083574-55083575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188921639 | chr11:55083584-55083585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534211767 | chr11:55083597-55083598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538409920 | chr11:55083609-55083610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550707136 | chr11:55083653-55083654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554291589 | chr11:55083657-55083658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577306586 | chr11:55083726-55083727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568814722 | chr11:55083747-55083748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540019618 | chr11:55083767-55083768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539514107 | chr11:55083768-55083769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192065263 | chr11:55083795-55083796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538492678 | chr11:55107497-55107498 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs61918407 | chr11:55107504-55107505 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs556418761 | chr11:55107523-55107524 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs368540818 | chr11:55107541-55107542 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs372038114 | chr11:55107558-55107559 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs182754619 | chr11:55107559-55107560 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs546474781 | chr11:55107580-55107581 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs146290080 | chr11:55107589-55107590 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs573516903 | chr11:55107593-55107594 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs540826683 | chr11:55107600-55107601 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs574942577 | chr11:55107607-55107608 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs112266150 | chr11:55107609-55107610 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs574458247 | chr11:55107634-55107635 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs187512702 | chr11:55107648-55107649 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs142846642 | chr11:55107650-55107651 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs544187503 | chr11:55107651-55107652 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs545389217 | chr11:55108132-55108133 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs558080132 | chr11:55109912-55109913 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs78976577 | chr11:55109921-55109922 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs117442637 | chr11:55109922-55109923 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs74832906 | chr11:55109932-55109933 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs571580369 | chr11:55110234-55110235 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs193168148 | chr11:55110249-55110250 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs10750871 | chr11:55110277-55110278 | Inactive region | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs565777810 | chr11:55110282-55110283 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs75919730 | chr11:55110440-55110441 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs531400410 | chr11:55110562-55110563 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21990379 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 17142309 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Alcoholism | 21790672 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Medulloblastoma | 21163964 | CNVD |
Breast cancer | 20369283 | CNVD |
Bipolar disorder | 19214233 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Obesity | 21131291 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:55083400-55083800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr11:55110800-55112400 | ZNF genes & repeats | iPS-18 Cell Line | embryonic stem cell |
3 | chr11:55120800-55121800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr11:55120800-55122200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr11:55121200-55121600 | Enhancers | Brain Hippocampus Middle | brain |
6 | chr11:55124200-55124400 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
7 | chr11:55149400-55149800 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |